This webinar will discuss these pitfalls and their impact on the industry. Despite the issues with cannabis laboratory testing, there are many opportunities for growth and improvement in the long run.
Recent years have seen a burgeoning scientific interest in the neurobiology of altered states of consciousness induced by psychedelic drugs (e.g. such as psilocybin, LSD, and DMT), also driven by renewed and growing evidence of their beneficial clinical effects in some psychiatric disorders.
The legalization of medical and recreational cannabis products across Canada and many US states has led to an increased demand for safe cannabis products.
Join Dr. Roger Kern as we explore state microbial limits for cannabis contamination as well as safe and effective treatments that enable plant material to pass these state limits.
This webinar will discuss the do’s and don’ts of potency analysis via HPLC. With the unerring interest in cannabis potency and the cannabinoid profile, it is more important than ever to make sure your cannabis analysis is at that top of its game.
In this webinar, we will discuss the AOAC process for creating a standard and adopting an OMA; review the standard for cannabinoids in hemp, and provide you with information about the AOAC Official Methods of Analysis for cannabinoids in hemp.
Join HPLC expert Dr. Lee Polite, President & Founder of Axion Analytical Labs, Inc as he discusses current analytical requirements for cannabis testing and how to develop and optimize a HPLC method from scratch using cannabinoids.